Regional operations hub, world-class talent pool and life-long partners; GSK and Singapore share an enduring bond.
GSK’s presence in Singapore stretches back to 1939 with the arrival of our first Resident Manager. We weathered a world war and a communist insurgency together with Singapore, and in 1959 we setup our first commercial operations office for Malaya in Singapore.
Today, with a large operational and manufacturing footprint supporting the production of nearly half of all GSK medicines worldwide, not many pharmaceutical companies share the deep roots that GSK and Singapore have.
A headquarters for Asia and the world
Over the past 50 years ‘The Little Red Dot’ has grown into a world-class hub for biomedical sciences and engineering. Since we first established commercial operations here 57 years ago, our presence has grown to include three global manufacturing sites and over 1800 employees. To date, we have invested over $1.5bn (£750m) in Singapore.
As we move into the next stage of our journey, we have invested in a new headquarters for Asia in Singapore. This symbolises the strategic significance of the Republic and the growing importance of Asia for our business. This new hub will allow us to better meet the health needs of patients and communities worldwide.
To effectively meet the needs of patients, it’s vitally important that we remain close to the communities we serve.
Developing our people
A key part of our strategy for building a globally diversified and robust business is the development of talent in Asia.
To accompany the new headquarters, we are transforming the way we develop our people. We are devising new leadership programmes specifically for Asia and growing the number of opportunities for graduates and postgraduates through global programmes like our Future Leaders Programme and ESPRIT programme.
We’ve enhanced our existing volunteering and community engagement platforms to make Corporate Social Responsibility an integral part of our people development. To effectively meet the needs of patients, it’s vitally important that we remain close to the communities we serve. To do this, we are working with a wide variety of NGOs, community and government organisations to ensure we remain engaged and responsive to healthcare issues in Asia.
Manufacturing to the highest quality
Quality and patient safety are at the core of our manufacturing processes and we recognise the potential of Singapore to provide the unique and specialist skill sets required.
Quality and patient safety are at the core of our manufacturing.
Through our presence in Singapore, we are trialling cutting-edge continuous manufacturing processes as well as new, greener technology that will produce the highest quality products for patients and consumers, while reducing the environmental impact of manufacturing.